Marius Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MARIUS
MARIUS has one approved drug.
There are six US patents protecting MARIUS drugs.
Summary for Marius
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Marius
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Marius | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-001 | Jul 27, 2022 | DISCN | Yes | No | 11,617,758 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Marius | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | 12,403,146 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Marius | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | 11,590,146 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Marius Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2710149 | ⤷ Start Trial |
| European Patent Office | 2519230 | ⤷ Start Trial |
| European Patent Office | 2968137 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
